Literature DB >> 22224930

The triglyceride paradox in people of African descent.

Sophia S K Yu1, Darleen C Castillo, Amber B Courville, Anne E Sumner.   

Abstract

Even though insulin resistance, cardiovascular disease (CVD), and type 2 diabetes (T2D) are associated with hypertriglyceridemia, blacks with these conditions usually have normal triglyceride (TG) levels. This is often called a lipid paradox. More precisely, it is a "TG paradox." The pathways that lead to hypertriglyceridemia have been intensively explored. Yet, the pathways that allow TG levels to be normal in the presence of insulin resistance have received little attention and this is problematic. Tests designed for the early detection of insulin-resistant conditions often use elevated TG levels as a diagnostic criterion. However, insulin resistance, CVD, and T2D are not usually associated with hypertriglyceridemia in people of African descent; therefore, the widespread use of TG levels to predict these conditions needs re-evaluation. This review focuses on black-white differences in: (1) the lipid profile across North America, Europe, and Africa; (2) the efficacy of TG-based screening tests, specifically the metabolic syndrome and its two abbreviated versions, the hypertriglycerdemic waist and TG/high-density lipoprotein cholesterol (HDL-C) ratio; and (3) the mechanisms that allow TG to be normal even in the presence of insulin resistance. Overall, a broader understanding of how TG physiology varies by race could lead to better diagnostic tests and improved health outcomes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22224930      PMCID: PMC3311911          DOI: 10.1089/met.2011.0108

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  51 in total

1.  Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study.

Authors:  J P Després; C Couillard; J Gagnon; J Bergeron; A S Leon; D C Rao; J S Skinner; J H Wilmore; C Bouchard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

2.  Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population.

Authors:  Hermes Florez; Armando Mendez; Paul Casanova-Romero; Carmen Larreal-Urdaneta; Sumaya Castillo-Florez; David Lee; Ronald Goldberg
Journal:  Atherosclerosis       Date:  2005-11-18       Impact factor: 5.162

3.  Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B.

Authors:  A Chait; R L Brazg; D L Tribble; R M Krauss
Journal:  Am J Med       Date:  1993-04       Impact factor: 4.965

Review 4.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Richard Kahn; John Buse; Ele Ferrannini; Michael Stern
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

5.  LDL and HDL enriched in triglyceride promote abnormal cholesterol transport.

Authors:  Josephine W Skeggs; Richard E Morton
Journal:  J Lipid Res       Date:  2002-08       Impact factor: 5.922

6.  Ethnic differences in hepatic steatosis: an insulin resistance paradox?

Authors:  Richard Guerrero; Gloria L Vega; Scott M Grundy; Jeffrey D Browning
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

7.  Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and men.

Authors:  Tobias Pischon; Frank B Hu; Kathryn M Rexrode; Cynthia J Girman; Joann E Manson; Eric B Rimm
Journal:  Atherosclerosis       Date:  2007-08-02       Impact factor: 5.162

8.  Decreased whole body lipolysis as a mechanism of the lipid-lowering effect of pioglitazone in type 2 diabetic patients.

Authors:  Amalia Gastaldelli; Arturo Casolaro; Demetrio Ciociaro; Silvia Frascerra; Monica Nannipieri; Emma Buzzigoli; Ele Ferrannini
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-05-05       Impact factor: 4.310

9.  The role of diabetes and components of the metabolic syndrome in stroke and coronary heart disease mortality in U.K. white and African-Caribbean populations.

Authors:  Therese Tillin; Nita G Forouhi; Paul M McKeigue; Nish Chaturvedi
Journal:  Diabetes Care       Date:  2006-09       Impact factor: 19.112

10.  Relationship of glucose intolerance to coronary risk in Afro-Caribbeans compared with Europeans.

Authors:  N Chaturvedi; P M McKeigue; M G Marmot
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

View more
  36 in total

1.  Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the Coronary Artery Risk Development in Young Adults Study.

Authors:  Lisa B VanWagner; Hongyan Ning; Cora E Lewis; Christina M Shay; John Wilkins; J Jeffrey Carr; James G Terry; Donald M Lloyd-Jones; David R Jacobs; Mercedes R Carnethon
Journal:  Atherosclerosis       Date:  2014-06-10       Impact factor: 5.162

2.  Allostatic Load: Importance, Markers, and Score Determination in Minority and Disparity Populations.

Authors:  Erik J Rodriquez; Edward N Kim; Anne E Sumner; Anna M Nápoles; Eliseo J Pérez-Stable
Journal:  J Urban Health       Date:  2019-03       Impact factor: 3.671

3.  The relationship of oxidative stress, adiposity and metabolic risk factors in healthy Black and White American youth.

Authors:  J Warolin; K R Coenen; J L Kantor; L E Whitaker; L Wang; S A Acra; L J Roberts; M S Buchowski
Journal:  Pediatr Obes       Date:  2013-01-07       Impact factor: 4.000

4.  Metabolically Healthy Obesity Is Not Associated with Food Intake in White or Black Men.

Authors:  Ruth W Kimokoti; Suzanne E Judd; James M Shikany; P K Newby
Journal:  J Nutr       Date:  2015-09-30       Impact factor: 4.798

5.  Clusters of fatty acids in the serum triacylglyceride fraction associate with the disorders of type 2 diabetes.

Authors:  Luke W Johnston; Zhen Liu; Ravi Retnakaran; Bernard Zinman; Adria Giacca; Stewart B Harris; Richard P Bazinet; Anthony J Hanley
Journal:  J Lipid Res       Date:  2018-07-09       Impact factor: 5.922

6.  Food intake does not differ between obese women who are metabolically healthy or abnormal.

Authors:  Ruth W Kimokoti; Suzanne E Judd; James M Shikany; P K Newby
Journal:  J Nutr       Date:  2014-10-08       Impact factor: 4.798

7.  Improved Identification and Antihypertension Pharmacotherapy in Cardiorenal Metabolic Syndrome: Focus on Racial/Ethnic Minorities, Olmesartan Medoxomil, and Combination Therapy.

Authors:  Keith C Ferdinand
Journal:  Cardiorenal Med       Date:  2012-10-26       Impact factor: 2.041

8.  Triglyceride-based screening tests fail to recognize cardiometabolic disease in African immigrant and African-American men.

Authors:  Sophia S K Yu; Natalie L M Ramsey; Darleen C Castillo; Madia Ricks; Anne E Sumner
Journal:  Metab Syndr Relat Disord       Date:  2012-12-05       Impact factor: 1.894

9.  Elevated triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio increased risk of hyperuricemia: a 4-year cohort study in China.

Authors:  Xin-Yao Liu; Qiao-Yu Wu; Zhi-Heng Chen; Guang-Yu Yan; Yao Lu; Hai-Jiang Dai; Ying Li; Ping-Ting Yang; Hong Yuan
Journal:  Endocrine       Date:  2020-01-15       Impact factor: 3.633

10.  Triglyceride Paradox Is Related to Lipoprotein Size, Visceral Adiposity and Stearoyl-CoA Desaturase Activity in Black Versus White Women.

Authors:  Stephanie T Chung; Celeste K L Cravalho; Abby G Meyers; Amber B Courville; Shanna Yang; Nirupa Rachel Matthan; Lilian Mabundo; Maureen Sampson; Ronald Ouwerkerk; Ahmed M Gharib; Alice H Lichtenstein; Alan T Remaley; Anne E Sumner
Journal:  Circ Res       Date:  2019-10-18       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.